News

Cervical cancer rates are increasing in Puerto Rico, and researchers from Hollings and the island are working together to increase screening rates.

Most people with an inherited mutation that increases cancer risk have no idea – which is why genetic testing is so important, says Dr. Kevin Hughes.

Caregiving for family members with cancer can take an emotional and physical toll. Yet few caregivers are screened for distress or connected to resources.

New research shows that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

A drug that Hollings researchers were developing for cancer turns out to restore motor function in aging mice showing signs of neurodegeneration.

MUSC researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response.

An increase in cervical cancer deaths in Appalachian Kentucky could point to hidden issues in other regions of persistent poverty.

A clinical trial at MUSC Hollings Cancer Center is testing a shorter course of radiation therapy for sarcoma patients to ease the logistics of getting care.

Could preparing for and dealing with contagious illnesses such as COVID become as streamlined as getting ready for a storm?

New RSV vaccine for pregnant women and people aged 60 and up arrives at MUSC Health. “No-brainer” for people who qualify, says expert.